TREPONEMA PALLIDUM IGG^

TREPONEMA PALLIDUM IGG^ is a laboratory test that detects IgG antibodies specific to Treponema pallidum, the bacterium that causes syphilis. The test is performed on a small blood sample collected at home and analysed by Dubai‑accredited laboratories using sensitive immunoassays to determine past or ongoing exposure. Early and accurate detection is important for timely treatment and to reduce the risk of transmission; results are delivered confidentially to protect your privacy. Home collection is discreet and convenient while maintaining the same diagnostic standards as clinic‑based testing.

• Treponema pallidum IgG (TP‑IgG)
• Qualitative result (Reactive / Non‑Reactive)
• Signal/Cutoff ratio (S/CO) or antibody index

• After unprotected sexual contact or exposure to a partner with syphilis
• If you notice genital sores, rash, or unexplained skin lesions
• As part of routine sexual health screening for sexually active individuals
• During pregnancy or when planning pregnancy to protect maternal and fetal health
• If a sexual partner has received a positive syphilis diagnosis

• Accurate immunoassay testing performed by Dubai‑accredited laboratories
• Discreet at‑home blood collection with confidential reporting
• Fast turnaround and clear reactive/non‑reactive results
• Supports early detection and timely referral for treatment if needed

• At‑home blood sample collection (fingerprick or venous draw arranged by provider)
• No fasting required prior to the test
• Allow for a serological window period — consider repeat testing at 6–12 weeks after exposure if initial test is negative
• Suitable for adults and adolescents per local clinic guidance; follow-up with a healthcare professional for positive or equivocal results